MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tokita, K.
Right arrow Articles by Jensen, R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tokita, K.
Right arrow Articles by Jensen, R. T.

Vol. 61, Issue 6, 1435-1443, June 2002

Molecular Basis of the Selectivity of Gastrin-Releasing Peptide Receptor for Gastrin-Releasing Peptide

Kenji Tokita, Simon J. Hocart, David H. Coy, and Robert T. Jensen

Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland (K.T., R.T.J.); and Department of Medicine, Peptide Research Laboratories, Tulane University Health Sciences Center, New Orleans, Louisiana (S.J.H., D.H.C.)

The mammalian bombesin peptides [gastrin-releasing peptide (GRP) and neuromedin B (NMB)] are important in numerous biological and pathological processes. These effects are mediated by the heptahelical GRP receptor (GRPR) and NMB receptor (NMBR). GRP has high affinity for GRPR and lower affinity for NMBR. Almost nothing is known about the molecular basis for the selectivity of GRP. To address this question, we first studied four loss-of-affinity GRPR chimeric receptors formed by exchanging the four extracellular (EC) domains of GRPR with the corresponding NMBR EC domains. Receptors were transiently expressed, and affinities were determined by binding studies. Only substitution of the third EC domain (EC3) of GRPR markedly decreased GRP affinity. In the reverse study using gain-of-affinity NMBR chimeras, only replacement of EC3 of NMBR markedly increased GRP affinity. Replacing each of the 20 comparable EC3 amino acids that differed in the NMBR in GRPR showed that two separate NMBR substitutions in the GRPR, Ile for Phe185 or Ile for Ala198, markedly decreased GRP affinity. Additional point mutants demonstrated that an amino acid with an aromatic ring in position 185 of GRPR and the size of the backbone substitution in position 198 of GRPR were important for GRP selectivity. These results demonstrate that selectivity of GRP for GRPR over NMBR is primarily determined by two amino acid differences in the EC3 domains of the receptor. Our results suggest that an interaction between the aromatic ring of Phe185 of the GRPR with GRP is the most important for GRP selectivity.


Copyright © 2002 by U.S. Government



This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
R. T. Jensen, J. F. Battey, E. R. Spindel, and R. V. Benya
International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States
Pharmacol. Rev., March 1, 2008; 60(1): 1 - 42.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. Ashour, L. Shan, J. H. Lee, W. Schlicher, K. Wada, E. Wada, and M. E. Sunday
Bombesin Inhibits Alveolarization and Promotes Pulmonary Fibrosis in Newborn Mice
Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1377 - 1385.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. R. Grider
Gastrin-releasing peptide is a modulatory neurotransmitter of the descending phase of the peristaltic reflex
Am J Physiol Gastrointest Liver Physiol, December 1, 2004; 287(6): G1109 - G1115.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. W. Moody, S. A. Mantey, T. K. Pradhan, M. Schumann, T. Nakagawa, A. Martinez, J. Fuselier, D. H. Coy, and R. T. Jensen
Development of High Affinity Camptothecin-Bombesin Conjugates That Have Targeted Cytotoxicity for Bombesin Receptor-containing Tumor Cells
J. Biol. Chem., May 28, 2004; 279(22): 23580 - 23589.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Subramaniam, K. Sugiyama, D. H. Coy, Y. Kong, Y. E. Miller, P. F. Weller, K. Wada, E. Wada, and M. E. Sunday
Bombesin-like Peptides and Mast Cell Responses: Relevance to Bronchopulmonary Dysplasia?
Am. J. Respir. Crit. Care Med., September 1, 2003; 168(5): 601 - 611.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics